These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31905032)

  • 21. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
    Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
    Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of a real-time RT-qPCR for detection of Crimean-Congo hemorrhagic fever virus representing different genotypes.
    Jääskeläinen AJ; Kallio-Kokko H; Ozkul A; Bodur H; Korukruoglu G; Mousavi M; Pranav P; Vaheri A; Mirazimi A; Vapalahti O
    Vector Borne Zoonotic Dis; 2014 Dec; 14(12):870-2. PubMed ID: 25514124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies.
    Sas MA; Comtet L; Donnet F; Mertens M; Vatansever Z; Tordo N; Pourquier P; Groschup MH
    Antiviral Res; 2018 Mar; 151():24-26. PubMed ID: 29330092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual RNA-Seq characterization of host and pathogen gene expression in liver cells infected with Crimean-Congo Hemorrhagic Fever Virus.
    Kozak RA; Fraser RS; Biondi MJ; Majer A; Medina SJ; Griffin BD; Kobasa D; Stapleton PJ; Urfano C; Babuadze G; Antonation K; Fernando L; Booth S; Lillie BN; Kobinger GP
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008105. PubMed ID: 32251473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crimean-Congo Hemorrhagic Fever.
    Shayan S; Bokaean M; Shahrivar MR; Chinikar S
    Lab Med; 2015; 46(3):180-9. PubMed ID: 26199256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
    Lindquist ME; Zeng X; Altamura LA; Daye SP; Delp KL; Blancett C; Coffin KM; Koehler JW; Coyne S; Shoemaker CJ; Garrison AR; Golden JW
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus.
    Xu ZS; Du WT; Wang SY; Wang MY; Yang YN; Li YH; Li ZQ; Zhao LX; Yang Y; Luo WW; Wang YY
    Cell Res; 2024 Feb; 34(2):140-150. PubMed ID: 38182887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
    Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
    Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.
    Lombe BP; Saito T; Miyamoto H; Mori-Kajihara A; Kajihara M; Saijo M; Masumu J; Hattori T; Igarashi M; Takada A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.
    Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjärvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
    Elife; 2022 Apr; 11():. PubMed ID: 35437144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Feldmann H
    F1000Res; 2018; 7():. PubMed ID: 30416710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
    Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
    Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
    Spengler JR; Patel JR; Chakrabarti AK; Zivcec M; García-Sastre A; Spiropoulou CF; Bergeron É
    J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crimean-Congo hemorrhagic fever virus infection triggers the upregulation of the Wnt signaling pathway inhibitor genes.
    Papp H; Zeghbib S; Földes F; Banfai K; Madai M; Kemenesi G; Urbán P; Kvell K; Jakab F
    Virus Genes; 2020 Aug; 56(4):508-514. PubMed ID: 32335793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
    Elife; 2021 Jan; 10():. PubMed ID: 33416494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crimean-Congo hemorrhagic fever virus.
    Flick R; Whitehouse CA
    Curr Mol Med; 2005 Dec; 5(8):753-60. PubMed ID: 16375710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.
    Bertolotti-Ciarlet A; Smith J; Strecker K; Paragas J; Altamura LA; McFalls JM; Frias-Stäheli N; García-Sastre A; Schmaljohn CS; Doms RW
    J Virol; 2005 May; 79(10):6152-61. PubMed ID: 15858000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin.
    Bergeron É; Zivcec M; Chakrabarti AK; Nichol ST; Albariño CG; Spiropoulou CF
    PLoS Pathog; 2015 May; 11(5):e1004879. PubMed ID: 25933376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.